Daniel M Hoefner

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

John H. Contois, Joseph P. McConnell, Amar A Sethi et al. · Clinical Chemistry · 2009 · 326 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Development of a Rapid, Quantitative Method for LDL Subfractionation with Use of the Quantimetrix Lipoprint LDL System

Daniel M Hoefner, Shannon D Hodel, John F. O’Brien et al. · Clinical Chemistry · 2001 · 273 citations · Full text

Life Sciences, Biochemistry, Cardiology +15

Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment

Weihua Guan, Jing Cao, Brian T. Steffen et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 208 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

New Automated Assay of Small Dense Low-Density Lipoprotein Cholesterol Identifies Risk of Coronary Heart Disease

Michael Y. Tsai, Brian T. Steffen, Weihua Guan et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 184 citations

Medicine, Cardiology, Epidemiologic Methods +16

Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy–Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices

Thomas Cole, John H. Contois, György Csákó et al. · Clinical Chemistry · 2013 · 125 citations · Full text

Life Sciences, Biostatistics, Clinical Cardiology +13